Banking Recap

Chatham Lodging Trust Announces Acquisition for $92,000

Chatham Lodging Trust, a real estate investment trust trading under the ticker symbol CLDT, is acquiring assets in a transaction valued at $92 million. The transaction is classified as an asset acquisition within the mergers and acquisitions product group, and the sector involved is real estate. The specific identity of the target or assets being acquired has not been disclosed in available materials.

May 6, 2026·SEC EDGAR·pending regulatory·asset acquisition

Deal value

This briefing is sourced from an SEC EDGAR filing published on May 6, 2026. The specific form type of the filing is not identified in the available documentation. The deal is currently in pending regulatory status, indicating that it has not yet closed and remains subject to regulatory review or approval processes.

No financial advisors have been identified or extracted for this transaction. This is notable as asset acquisitions of this size often engage investment banking advisors, though in some cases REITs may execute transactions without formal banking advisors or such advisory relationships may not be publicly disclosed in the filing.

No legal advisors have been identified in the available documentation for either party to the transaction.

The deal structure specifies an asset acquisition with a disclosed transaction value of $92 million in USD. Beyond the total consideration, no additional detail regarding the composition of consideration, payment mechanics, timing, or specific asset classes or properties being acquired has been disclosed.

Several material details remain unknown. The specific form type of the SEC filing has not been identified. The identity of the target or the specific assets being acquired is not disclosed. The expected closing date for the transaction has not been provided. No information is available regarding the consideration mix, payment schedule, financing structure, or whether any portion of the purchase price is contingent. The filing does not identify the seller or target entity. Additionally, while the deal is noted as pending regulatory approval, the specific regulatory body or bodies whose approval is required has not been specified.